Citigroup’s Herbalife HLF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.94M Sell
200,000
-200,000
-50% -$3.27M ﹤0.01% 2394
2025
Q4
$5.16M Hold
400,000
﹤0.01% 1988
2025
Q3
$3.38M Sell
400,000
-250,000
-38% -$2.36M ﹤0.01% 2272
2025
Q2
$5.6M Buy
650,000
+550,000
+550% +$4.09M ﹤0.01% 1793
2025
Q1
$863K Buy
+100,000
New +$711K ﹤0.01% 3351
2023
Q1
Sell
-74,100
Closed -$1.1M 5645
2022
Q4
$1.1M Hold
74,100
﹤0.01% 2531
2022
Q3
$1.47M Sell
74,100
-81,100
-52% -$2.01M ﹤0.01% 2398
2022
Q2
$3.17M Buy
+155,200
New +$3.84M ﹤0.01% 1785
2021
Q1
Sell
-86,400
Closed -$4.15M 6742
2020
Q4
$4.15M Sell
86,400
-900
-1% -$43.4K ﹤0.01% 2219
2020
Q3
$4.07M Sell
87,300
-76,300
-47% -$3.75M ﹤0.01% 2043
2020
Q2
$7.36M Sell
163,600
-23,300
-12% -$905K 0.01% 1555
2020
Q1
$5.45M Sell
186,900
-73,500
-28% -$2.74M ﹤0.01% 1591
2019
Q4
$12.4M Buy
260,400
+100,600
+63% +$4.36M 0.01% 1300
2019
Q3
$6.05M Buy
159,800
+43,400
+37% +$1.69M ﹤0.01% 1775
2019
Q2
$4.98M Buy
116,400
+30,600
+36% +$1.45M ﹤0.01% 1979
2019
Q1
$4.55M Sell
85,800
-806,400
-90% -$46.3M ﹤0.01% 1878
2018
Q4
$52.6M Buy
892,200
+114,000
+15% +$6.29M 0.05% 387
2018
Q3
$42.5M Buy
778,200
+25,700
+3% +$1.42M 0.04% 466
2018
Q2
$40.4M Sell
752,500
-71,700
-9% -$3.77M 0.04% 443
2018
Q1
$40.2M Buy
824,200
+336,200
+69% +$14.3M 0.03% 468
2017
Q4
$16.5M Sell
488,000
-145,400
-23% -$5.09M 0.01% 960
2017
Q3
$21.5M Buy
633,400
+76,200
+14% +$2.61M 0.02% 751
2017
Q2
$19.9M Buy
557,200
+108,000
+24% +$3.64M 0.02% 753
2017
Q1
$13.1M Buy
449,200
+163,600
+57% +$4.55M 0.01% 965
2016
Q4
$6.87M Sell
285,600
-17,800
-6% -$486K 0.01% 1515
2016
Q3
$9.4M Buy
303,400
+126,400
+71% +$3.99M 0.01% 1132
2016
Q2
$5.18M Buy
177,000
+75,200
+74% +$2.25M 0.01% 1561
2016
Q1
$3.13M Sell
101,800
-855,400
-89% -$22.1M ﹤0.01% 1997
2015
Q4
$25.7M Buy
957,200
+85,200
+10% +$2.37M 0.03% 625
2015
Q3
$23.8M Sell
872,000
-154,400
-15% -$4.23M 0.02% 638
2015
Q2
$28.3M Sell
1,026,400
-244,400
-19% -$5.92M 0.03% 617
2015
Q1
$27.2M Sell
1,270,800
-1,929,400
-60% -$32.9M 0.03% 613
2014
Q4
$60.3M Buy
3,200,200
+805,600
+34% +$17.2M 0.05% 342
2014
Q3
$52.4M Buy
2,394,600
+235,200
+11% +$6.28M 0.05% 370
2014
Q2
$69.7M Buy
2,159,400
+447,800
+26% +$13.7M 0.07% 272
2014
Q1
$49M Sell
1,711,600
-334,600
-16% -$11.1M 0.05% 331
2013
Q4
$80.5M Sell
2,046,200
-22,600
-1% -$783K 0.07% 248
2013
Q3
$72.2M Sell
2,068,800
-80,200
-4% -$2.48M 0.07% 256
2013
Q2
$48.5M Buy
+2,149,000
New +$45.8M 0.05% 321

Other funds holding HLF

Citigroup's HLF Position: Q1 2026 in Review

Citigroup reduced its Herbalife (HLF) stake by 31% in Q1 2026, selling an estimated $8.37M and leaving 1,162,649 shares worth $17.1M. The position accounts for 0.01% of the portfolio, ranked #1159.

Citigroup first reported a position in HLF in Q2 2013 and has held it in 52 quarters since. The position peaked at $42M in Q2 2020. 252 funds tracked by Wall St. Rank hold HLF as of Q1 2026.

  • Citigroup held 1,162,649 shares of Herbalife worth $17.1M as of Q1 2026.
  • Citigroup sold 512,480 Herbalife shares in Q1 2026, an estimated $8.37M.
  • Herbalife made up 0.01% of Citigroup's portfolio in Q1 2026, its #1159 holding.
  • Citigroup first reported a position in Herbalife in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Herbalife position peaked at $42M in Q2 2020.
  • 252 funds tracked by Wall St. Rank held Herbalife as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.